Fadi Haddad, Assistant Professor at MD Anderson Cancer Center, shared a post on X:
“Out in ACS Journal Cancer, Updates on the management of CML in 2025
Treatment options 1/2+ lines
Optimal biologic dosing
Cost of therapy
Perspective from experts accross different countries.”
Title: Management of chronic myeloid leukemia in 2025
Authors: Hagop Kantarjian, Massimo Breccia, Fadi Haddad, Rüdiger Hehlmann, Ghayas Issa, Hemant Malhotra, Franck Nicolini, Koji Sasaki, Leif Stenke, Elias Jabbour
Read the Full Article on ACS Journal Cancer.
More posts featuring Fadi Haddad.
